ORGS logo

Orgenesis (ORGS) Free Cash Flow

Annual FCF

-$16.93 M
+$20.41 M+54.65%

31 December 2023

ORGS Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$4.69 M
+$1.22 M+20.65%

30 September 2024

ORGS Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$15.74 M
-$3.21 M-25.58%

30 September 2024

ORGS TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ORGS Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+54.6%-216.5%+51.8%
3 y3 years+78.7%+53.9%+78.5%
5 y5 years+20.3%+17.3%+24.9%

ORGS Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+78.7%-833.9%+71.1%-25.6%+78.5%
5 y5 yearsat high+78.7%-833.9%+89.7%-25.6%+80.2%
alltimeall time<-9999.0%+78.7%-3311.0%+89.7%<-9999.0%+80.2%

Orgenesis Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$4.69 M(-20.6%)
-$15.74 M(+25.6%)
June 2024
-
-$5.91 M(+27.2%)
-$12.54 M(-4.0%)
Mar 2024
-
-$4.64 M(+825.3%)
-$13.05 M(-22.9%)
Dec 2023
-$16.93 M(-54.7%)
-$502.00 K(-66.1%)
-$16.93 M(-48.1%)
Sept 2023
-
-$1.48 M(-76.9%)
-$32.64 M(-15.7%)
June 2023
-
-$6.42 M(-24.6%)
-$38.73 M(-8.2%)
Mar 2023
-
-$8.53 M(-47.4%)
-$42.17 M(+12.9%)
Dec 2022
-$37.34 M(+7.5%)
-$16.21 M(+113.9%)
-$37.34 M(+32.9%)
Sept 2022
-
-$7.58 M(-23.2%)
-$28.10 M(-8.5%)
June 2022
-
-$9.86 M(+167.0%)
-$30.70 M(-7.9%)
Mar 2022
-
-$3.69 M(-47.0%)
-$33.35 M(-4.0%)
Dec 2021
-$34.73 M(-56.4%)
-$6.97 M(-31.5%)
-$34.73 M(-52.6%)
Sept 2021
-
-$10.17 M(-18.7%)
-$73.22 M(-0.2%)
June 2021
-
-$12.51 M(+146.4%)
-$73.35 M(+4.4%)
Mar 2021
-
-$5.08 M(-88.8%)
-$70.26 M(-11.7%)
Dec 2020
-$79.57 M(+213.9%)
-$45.46 M(+341.2%)
-$79.57 M(+85.8%)
Sept 2020
-
-$10.30 M(+9.4%)
-$42.82 M(+12.1%)
June 2020
-
-$9.42 M(-34.6%)
-$38.19 M(+11.7%)
Mar 2020
-
-$14.39 M(+65.2%)
-$34.19 M(+34.9%)
Dec 2019
-$25.35 M(+19.4%)
-$8.71 M(+53.8%)
-$25.35 M(+20.9%)
Sept 2019
-
-$5.67 M(+4.5%)
-$20.97 M(-7.5%)
June 2019
-
-$5.42 M(-2.3%)
-$22.67 M(-6.1%)
Mar 2019
-
-$5.55 M(+28.0%)
-$24.14 M(+13.7%)
Nov 2018
-$21.24 M(+341.7%)
-$4.33 M(-41.1%)
-$21.24 M(+20.4%)
Aug 2018
-
-$7.36 M(+6.8%)
-$17.64 M(+45.7%)
May 2018
-
-$6.89 M(+160.8%)
-$12.10 M(+59.3%)
Feb 2018
-
-$2.64 M(+260.7%)
-$7.60 M(+58.0%)
Nov 2017
-$4.81 M(-7.7%)
-$733.00 K(-60.0%)
-$4.81 M(-4.9%)
Aug 2017
-
-$1.83 M(-23.3%)
-$5.06 M(+10.5%)
May 2017
-
-$2.39 M(-1736.3%)
-$4.58 M(+35.9%)
Feb 2017
-
$146.00 K(-114.9%)
-$3.37 M(-35.3%)
Nov 2016
-$5.21 M
-$982.00 K(-27.4%)
-$5.21 M(-3.0%)
DateAnnualQuarterlyTTM
Aug 2016
-
-$1.35 M(+14.7%)
-$5.37 M(+1.3%)
May 2016
-
-$1.18 M(-30.4%)
-$5.30 M(+11.9%)
Feb 2016
-
-$1.70 M(+48.0%)
-$4.74 M(+28.4%)
Nov 2015
-$3.69 M(+157.2%)
-$1.15 M(-10.7%)
-$3.69 M(+28.3%)
Aug 2015
-
-$1.28 M(+108.8%)
-$2.87 M(+62.3%)
May 2015
-
-$614.00 K(-5.1%)
-$1.77 M(+12.0%)
Feb 2015
-
-$647.00 K(+95.5%)
-$1.58 M(+10.3%)
Nov 2014
-$1.43 M(-28.2%)
-$331.00 K(+85.6%)
-$1.43 M(-8.5%)
Aug 2014
-
-$178.30 K(-58.0%)
-$1.57 M(-19.3%)
May 2014
-
-$424.70 K(-15.1%)
-$1.94 M(-5.1%)
Feb 2014
-
-$500.00 K(+7.6%)
-$2.05 M(+2.5%)
Nov 2013
-$2.00 M(+88.2%)
-$464.80 K(-15.9%)
-$2.00 M(+8.8%)
Aug 2013
-
-$552.80 K(+4.3%)
-$1.83 M(+15.0%)
May 2013
-
-$529.90 K(+17.8%)
-$1.60 M(+14.6%)
Feb 2013
-
-$449.70 K(+48.6%)
-$1.39 M(+31.1%)
Nov 2012
-$1.06 M(>+9900.0%)
-$302.60 K(-3.3%)
-$1.06 M(+39.2%)
Aug 2012
-
-$313.00 K(-4.1%)
-$762.50 K(+69.3%)
May 2012
-
-$326.50 K(+173.9%)
-$450.40 K(+260.0%)
Feb 2012
-
-$119.20 K(+3036.8%)
-$125.10 K(>+9900.0%)
Nov 2011
-$200.00(-98.7%)
-$3800.00(+322.2%)
-$200.00(-133.3%)
Aug 2011
-
-$900.00(-25.0%)
$600.00(-150.0%)
May 2011
-
-$1200.00(-121.1%)
-$1200.00(-120.0%)
Feb 2011
-
$5700.00(-290.0%)
$6000.00(-140.3%)
Nov 2010
-$15.00 K(-61.1%)
-$3000.00(+11.1%)
-$14.90 K(+8.8%)
Aug 2010
-
-$2700.00(-145.0%)
-$13.70 K(-39.4%)
May 2010
-
$6000.00(-139.5%)
-$22.60 K(-41.5%)
Feb 2010
-
-$15.20 K(+744.4%)
-$38.60 K(0.0%)
Nov 2009
-$38.60 K(<-9900.0%)
-$1800.00(-84.5%)
-$38.60 K(+4.9%)
Aug 2009
-
-$11.60 K(+16.0%)
-$36.80 K(+46.0%)
May 2009
-
-$10.00 K(-34.2%)
-$25.20 K(+65.8%)
Feb 2009
-
-$15.20 K
-$15.20 K
Nov 2008
$0.00
-
-

FAQ

  • What is Orgenesis annual free cash flow?
  • What is the all time high annual FCF for Orgenesis?
  • What is Orgenesis annual FCF year-on-year change?
  • What is Orgenesis quarterly free cash flow?
  • What is the all time high quarterly FCF for Orgenesis?
  • What is Orgenesis quarterly FCF year-on-year change?
  • What is Orgenesis TTM free cash flow?
  • What is the all time high TTM FCF for Orgenesis?
  • What is Orgenesis TTM FCF year-on-year change?

What is Orgenesis annual free cash flow?

The current annual FCF of ORGS is -$16.93 M

What is the all time high annual FCF for Orgenesis?

Orgenesis all-time high annual free cash flow is $0.00

What is Orgenesis annual FCF year-on-year change?

Over the past year, ORGS annual free cash flow has changed by +$20.41 M (+54.65%)

What is Orgenesis quarterly free cash flow?

The current quarterly FCF of ORGS is -$4.69 M

What is the all time high quarterly FCF for Orgenesis?

Orgenesis all-time high quarterly free cash flow is $146.00 K

What is Orgenesis quarterly FCF year-on-year change?

Over the past year, ORGS quarterly free cash flow has changed by -$3.21 M (-216.54%)

What is Orgenesis TTM free cash flow?

The current TTM FCF of ORGS is -$15.74 M

What is the all time high TTM FCF for Orgenesis?

Orgenesis all-time high TTM free cash flow is $6000.00

What is Orgenesis TTM FCF year-on-year change?

Over the past year, ORGS TTM free cash flow has changed by +$16.89 M (+51.76%)